ReviewNature nanotechnology2022

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines.

Janos Szebeni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.